EMSAM Pages on BioPortfolio:

Biotechnology News EMSAM Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/EMSAM-news.htm...

BioPortfolio - Mylan Inc. - Dey L.P. to Market EMSAM(R) Skin Patch ...
Archive News & Video for Friday, 29 May, 2009 | Reuters.com Dey L.P. to Market EMSAM(R) Skin. Patch for Treatment of Major Depressive Disorder 07:30 AM EDT.
...
http://www.bioportfolio.com/news/Dey_L.P._to_Market_EMSAM(R)...

BioPortfolio's Approved Drugs News by Tradename - E
EMSAM · EMTRICITABINE · EMTRIVA · E-MYCIN · ENABLEX · ENALAPRIL_MALEATE · ENALAPRILAT ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_n...

BioPortfolio - Emsam
Emsam - BioPortfolio - Indepth. ... BioPortfolio's Approved Drugs Database. Emsam. Selegiline. Download PDF containing detailed information. PDF Version ...
http://www.bioportfolio.com/indepth/Emsam.html...

BioPortfolio - MTI - Profile
Services and the Bamyan. Provincial Hospital Team up. Dey L.P. to Market EMSAM(R ) ... distribute EMSAM(R) in the U.S.. EMSAM, a selegiline ...
http://www.bioportfolio.com/biocorporate/26844-MTI.pdf...

The World Market for Psychotherapeutic Drugs
EMSAM. Format PDF Jan 1, 2007 292 Pages - Pub ID: KLI1340128 Table of Contents Price: $3500.00 / GBP2,310.00. Buy Biotechnology Management Reports online ...
http://www.bioportfolio.com/cgi-bin/acatalog/The_World_Marke...

BioPortfolio News: BioPortfolio News 2009-05-29
07:30: Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder. http://www.bioportfolio.com/news/Dey_L. ...
http://www.bioportfolio.com/news/2009-05-29.html...

BioPortfolio - Mylan Inc. - Mylan Acquires Remaining Interest in ...
Somerset developed EMSAM(R), a transdermal patch for the treatment of major depressive disorder, currently marketed in the United States by ...
http://www.bioportfolio.com/news/Mylan_Acquires_Remaining_In...

Results from other life science and pharmaceutical sites:

Emsam - Wikipedia, the free encyclopedia
Emsam (selegiline transdermal system) is a transdermal patch using the monoamine oxidase inhibitor (MAOI) selegiline. Selegiline, in small doses, ...
http://en.wikipedia.org/wiki/Emsam...

EMSAM® [EM sam]
Read this Medication Guide carefully before you start using EMSAM and each time you ... What is the most important information I should know about EMSAM? ...
http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088589.pdf...

emsam (Selegiline) patch [Somerset] - DailyMed: About DailyMed
Anyone considering the use of EMSAM or any other antidepressant in a child or adolescent must balance this risk with the clinical need. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=5033...

FDA Approves Emsam (Selegiline) as First Drug Patch for Depression
18 Jun 2009 ... The Food and Drug Administration today approved Emsam (selegiline), the first skin (transdermal) patch for use in treating major depression.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/20...

The Selegiline Transdermal System (Emsam)
Transdermal selegiline (Emsam, Somerset/Bristol-Myers Squibb) is the first therapeutic option of its kind to be approved by the Food and Drug
Administration ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27...

NDA 21-336 EMSAM (selegiline transdermal sysytem
Over 2500 patients with depression were treated with EMSAM (20-40mg) without dietary restrictions (820 patient-years of exposure). ...
http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4186S2_02...

Transdermal selegiline (Emsam).
Transdermal selegiline (Emsam). [No authors listed]. Mesh Terms: Administration, Cutaneous; Antiparkinson Agents/adverse effects ...
http://www.ncbi.nlm.nih.gov/pubmed/16770292...

Emsam (selegiline transdermal system) Patches
19 Jun 2009 ... Due to limited data, Emsam at any dose should not be used in children under the age of 12 years even when administered with dietary ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...

The selegiline transdermal system (emsam): a therapeutic option ...
The selegiline transdermal system (emsam): a therapeutic option for the treatment of major depressive disorder. Jessen L, Kovalick LJ, Azzaro AJ. ...
http://www.ncbi.nlm.nih.gov/pubmed/19750165...

EMSAM Selegiline Transdermal System NDA 21336/21708 ...
TSF = tyramine sensitivity factor calculated as the ratio of baseline average pressor dose to EMSAM interaction pressor dose. ...
http://www.fda.gov/ohrms/dockets/AC/05/briefing/2005-4186B2_...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.